Table: Kubota Pharmaceutical Holdings -2021 group results (IFRS)

Kubota Pharmaceutical Holdings

14/02/2022 06:01

Feb 14 (Reuters)- 
              Kubota Pharmaceutical Holdings Co., Ltd. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   Year ended      Year ended        Year to         NEXT  
                Dec 31, 2021    Dec 31, 2020    Dec 31, 2022       YEAR    
                   LATEST         YEAR-AGO         COMPANY       COMPANY   
                   RESULTS         RESULT         FORECAST     H1 FORECAST 
  Sales                            38 mln                                  
  Operating       loss 2.59       loss 2.48       loss 2.00                
  Pretax          loss 2.62       loss 2.44       loss 2.00                
  Net             loss 2.62       loss 2.44       loss 2.00                
  EPS Basic    loss 57.46 yen  loss 56.90 yen  loss 43.61 yen              
  EPS Diluted  loss 57.46 yen  loss 56.90 yen                              
  Ann Div            NIL             NIL             NIL                   
  -Q2 Div            NIL             NIL             NIL                   
  -Q4 Div            NIL             NIL             NIL                   
 
  NOTE - Kubota Pharmaceutical Holdings Co., Ltd.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company.
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T